Difference between revisions of "Parasite Experiment ontology"
| Line 57: | Line 57: | ||
****[[Nucleic_Acid|nucleic_acid]] | ****[[Nucleic_Acid|nucleic_acid]] | ||
****[[Primer|primer]] | ****[[Primer|primer]] | ||
| − | |||
| − | |||
| − | |||
*****[[3_Prime_Primer|3_prime_primer]] | *****[[3_Prime_Primer|3_prime_primer]] | ||
******[[3_Prime_Forward_Primer|3_prime_forward_primer]] | ******[[3_Prime_Forward_Primer|3_prime_forward_primer]] | ||
******[[3_Prime_Reverse_Primer|3_prime_reverse_primer]] | ******[[3_Prime_Reverse_Primer|3_prime_reverse_primer]] | ||
| + | *****[[5_Prime_Primer|5_prime_primer]] | ||
| + | ******[[5_Prime_Forward_Primer|5_prime_forward_primer]] | ||
| + | ******[[5_Prime_Reverse_Primer|5_prime_reverse_primer]] | ||
****[[Purity|purity]] | ****[[Purity|purity]] | ||
****[[Transfection_Buffer|transfection_buffer]] | ****[[Transfection_Buffer|transfection_buffer]] | ||
| Line 147: | Line 147: | ||
<td> | <td> | ||
<ul> | <ul> | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
<li>[[3 Prime Forward Primer]]</li> | <li>[[3 Prime Forward Primer]]</li> | ||
<li>[[3 Prime Intergenic Forward Region]]</li> | <li>[[3 Prime Intergenic Forward Region]]</li> | ||
| Line 159: | Line 153: | ||
<li>[[3 Prime Primer]]</li> | <li>[[3 Prime Primer]]</li> | ||
<li>[[3 Prime Reverse Primer]]</li> | <li>[[3 Prime Reverse Primer]]</li> | ||
| + | <li>[[5 Prime Forward Primer]]</li> | ||
| + | <li>[[5 Prime Intergenic Forward Region]]</li> | ||
| + | <li>[[5 Prime Intergenic Region]]</li> | ||
| + | <li>[[5 Prime Intergenic Reverse Region]]</li> | ||
| + | <li>[[5 Prime Primer]]</li> | ||
| + | <li>[[5 Prime Reverse Primer]]</li> | ||
</ul> | </ul> | ||
;A | ;A | ||
Revision as of 16:09, 12 January 2011
| What is Parasite Experiment Ontology (PEO)? |
|
The ontology comprehensively models the processes, instruments, parameters, and sample details that will be used to annotate experimental results with “provenance” metadata (derivation history of results). For example, given a drug selected sample (a sample that has been grown under selective drug pressure. source: Parasite Experiment ontology), details about the drug, drug concentration, the duration for the drug selection process, and the transfected sample used as input to the drug selection process are modeled in the ontology. This extensive provenance metadata modeled in this ontology will enable publication of results in journals, conferences with details of the method used to arrive at the result. PEO has 110 classes and 27 properties with a logic expressivity of ALCHQ(D) and incorporates concepts defined in Parasite Life Cycle ontology (PLO) to maximize reuse of existing ontological resources. The new version of PEO (ver 0.2) was released for listing and public use at NCBO’s BioPortal in December 2009. |
|
|
 Snapshot of class hierarchy of the parasite experiment ontology using Protege toolkit. Detail of this ontology is available at NCBO BioPortal |
| Feedback/Comments |
|
Please add feedback/comments in Discussion Section on the top of this wiki page. |
